2023 Q2 Form 10-Q Financial Statement

#000163159623000023 Filed on April 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $166.6M $157.1M $79.66M
YoY Change 75.91% 97.26% 20.84%
Cost Of Revenue $115.7M $106.0M $32.46M
YoY Change 158.59% 226.49% 18.55%
Gross Profit $50.92M $51.16M $47.20M
YoY Change 1.9% 8.4% 22.47%
Gross Profit Margin 30.57% 32.56% 59.25%
Selling, General & Admin $11.88M $13.02M $8.133M
YoY Change 39.01% 60.14% -10.03%
% of Gross Profit 23.33% 25.46% 17.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $70.87M $76.25M $11.79M
YoY Change 183.71% 546.78% 40.35%
Operating Profit -$19.95M -$25.09M $35.41M
YoY Change -179.8% -170.84% 17.49%
Interest Expense $115.7M $106.0M $32.46M
YoY Change 158.59% 226.49% 18.54%
% of Operating Profit 91.66%
Other Income/Expense, Net $6.972M $4.610M $6.430M
YoY Change 69.84% -28.3% 456.23%
Pretax Income -$19.95M -$25.09M $35.41M
YoY Change -179.8% -170.84% 17.49%
Income Tax $177.0K $169.0K $0.00
% Of Pretax Income 0.0%
Net Earnings -$25.77M -$25.08M $35.47M
YoY Change -202.84% -170.7% 17.87%
Net Earnings / Revenue -15.47% -15.96% 44.52%
Basic Earnings Per Share -$0.37 -$0.45 $0.47
Diluted Earnings Per Share -$0.37 -$0.45 $0.46
COMMON SHARES
Basic Shares Outstanding 69.10M shares 69.10M shares 63.09M shares
Diluted Shares Outstanding 69.12M shares 69.10M shares 69.40M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $207.7M $254.1M $173.2M
YoY Change 75.99% 46.73% -17.26%
Cash & Equivalents $207.7M $254.1M $173.2M
Short-Term Investments
Other Short-Term Assets $1.200M $700.0K $700.0K
YoY Change 50.0% 0.0% 250.0%
Inventory
Prepaid Expenses
Receivables $39.51M $40.51M $20.49M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $248.4M $295.3M $194.4M
YoY Change 75.04% 51.93% -14.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $35.49M $35.72M $36.60M
YoY Change -3.52% -2.39% 8.91%
Other Assets $19.50M $16.80M $6.300M
YoY Change 47.73% 166.67% 173.91%
Total Long-Term Assets $7.361B $7.581B $6.955B
YoY Change -2.78% 8.99% 37.82%
TOTAL ASSETS
Total Short-Term Assets $248.4M $295.3M $194.4M
Total Long-Term Assets $7.361B $7.581B $6.955B
Total Assets $7.609B $7.876B $7.150B
YoY Change -1.35% 10.16% 35.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.935M $3.712M $3.126M
YoY Change 23.66% 18.75% 346.57%
Accrued Expenses $19.87M $23.90M $12.03M
YoY Change 70.71% 98.69% 8.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $61.84M $65.78M $53.23M
YoY Change 16.62% 23.57% 29.84%
LONG-TERM LIABILITIES
Long-Term Debt $6.084B $6.293B $5.445B
YoY Change 1.71% 15.57% 30.31%
Other Long-Term Liabilities $4.100M $4.200M $1.800M
YoY Change 46.43% 133.33%
Total Long-Term Liabilities $6.088B $6.297B $5.447B
YoY Change 1.73% 15.61% 30.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $61.84M $65.78M $53.23M
Total Long-Term Liabilities $6.088B $6.297B $5.447B
Total Liabilities $6.149B $6.363B $5.500B
YoY Change 1.86% 15.69% 30.35%
SHAREHOLDERS EQUITY
Retained Earnings -$257.5M -$202.0M -$37.62M
YoY Change 434.72% 437.07% -37.75%
Common Stock $691.0K $691.0K $679.0K
YoY Change -0.86% 1.77% 22.12%
Preferred Stock
YoY Change
Treasury Stock (at cost) $61.00M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $1.460B $1.513B $1.650B
YoY Change
Total Liabilities & Shareholders Equity $7.609B $7.876B $7.150B
YoY Change -1.35% 10.16% 35.6%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$25.77M -$25.08M $35.47M
YoY Change -202.84% -170.7% 17.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $35.47M $41.64M $33.13M
YoY Change 0.62% 25.67% 9.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $172.5M -$113.1M -$530.5M
YoY Change -128.11% -78.68% 163.66%
Cash From Investing Activities $172.5M -$113.1M -$530.5M
YoY Change -128.11% -78.68% 163.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $135.3M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -251.3M $87.14M $398.5M
YoY Change -147.5% -78.13% 47.86%
NET CHANGE
Cash From Operating Activities 35.47M $41.64M $33.13M
Cash From Investing Activities 172.5M -$113.1M -$530.5M
Cash From Financing Activities -251.3M $87.14M $398.5M
Net Change In Cash -43.40M $15.70M -$98.88M
YoY Change -11.82% -115.88% -200.37%
FREE CASH FLOW
Cash From Operating Activities $35.47M $41.64M $33.13M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001631596
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#ProfitLossFromRealEstateOperations
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38082
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
KKR Real Estate Finance Trust Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2009094
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
30 Hudson Yards,
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 7500
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
CY2023Q1 dei City Area Code
CityAreaCode
212
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
750-8300
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69095011 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
254096000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
239791000 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
7612238000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
7494138000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
167360000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
106974000 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
7444878000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
7387164000 usd
CY2023Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
81100000 usd
CY2022Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
80231000 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
40512000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
39005000 usd
CY2023Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
35719000 usd
CY2022Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
36849000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
19726000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
19281000 usd
CY2023Q1 us-gaap Assets
Assets
7876031000 usd
CY2022Q4 us-gaap Assets
Assets
7802321000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
3875261000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
3748691000 usd
CY2023Q1 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
1937602000 usd
CY2022Q4 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
1935592000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
336464000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
336828000 usd
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
143579000 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
143237000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
29711000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
29711000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
21699000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
17859000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
10112000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
10245000 usd
CY2023Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
8458000 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
8722000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6362886000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6230885000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75080707 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75080707 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69095011 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69095011 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
691000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
691000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1811135000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1808983000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202024000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-141503000 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5985696 shares
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
46554000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5985696 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
96764000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
96764000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1513169000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1571538000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
-24000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-102000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1513145000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1571436000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7876031000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7802321000 usd
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
152530000 usd
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
73230000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
105976000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
32459000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
40771000 usd
CY2023Q1 us-gaap Profit Loss From Real Estate Operations
ProfitLossFromRealEstateOperations
2246000 usd
CY2022Q1 us-gaap Profit Loss From Real Estate Operations
ProfitLossFromRealEstateOperations
2629000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-347000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1886000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2711000 usd
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1915000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4610000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6430000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4690000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4446000 usd
CY2023Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
60467000 usd
CY2022Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1218000 usd
CY2023Q1 kref Management Fees To Affiliate
ManagementFeesToAffiliate
6523000 usd
CY2022Q1 kref Management Fees To Affiliate
ManagementFeesToAffiliate
6007000 usd
CY2023Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
1811000 usd
CY2022Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
0 usd
CY2023Q1 kref Property Operating Expense
PropertyOperatingExpense
2758000 usd
CY2022Q1 kref Property Operating Expense
PropertyOperatingExpense
2554000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
76249000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11789000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25085000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35412000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
169000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-25254000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
35412000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-177000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-56000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25077000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35468000 usd
CY2023Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
5326000 usd
CY2022Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
5326000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
407000 usd
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
346000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30810000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29796000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69095011 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63086452 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69095011 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69402626 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2023Q1 kref Participating Security Dividends Per Share Declared
ParticipatingSecurityDividendsPerShareDeclared
0.43
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2022Q1 kref Participating Security Dividends Per Share Declared
ParticipatingSecurityDividendsPerShareDeclared
0.43
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-25254000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
35412000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6796000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4844000 usd
CY2023Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
5888000 usd
CY2022Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
6083000 usd
CY2023Q1 kref Payments For Interest Paid In Kind
PaymentsForInterestPaidInKind
0 usd
CY2022Q1 kref Payments For Interest Paid In Kind
PaymentsForInterestPaidInKind
464000 usd
CY2023Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
-1130000 usd
CY2022Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
1058000 usd
CY2023Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
60467000 usd
CY2022Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1218000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2152000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2126000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1507000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
3850000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-658000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-985000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3841000 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2901000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-605000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-532000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-155000 usd
CY2022Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
67000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41635000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33130000 usd
CY2023Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
89669000 usd
CY2022Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
282282000 usd
CY2023Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
201881000 usd
CY2022Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
812756000 usd
CY2023Q1 kref Payments For Capital Expenditures Real Estate Owned
PaymentsForCapitalExpendituresRealEstateOwned
868000 usd
CY2022Q1 kref Payments For Capital Expenditures Real Estate Owned
PaymentsForCapitalExpendituresRealEstateOwned
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-113080000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-530474000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
162436000 usd
CY2022Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
479329000 usd
CY2023Q1 kref Proceeds From Issuance Of Collateralized Loan Obligation
ProceedsFromIssuanceOfCollateralizedLoanObligation
0 usd
CY2022Q1 kref Proceeds From Issuance Of Collateralized Loan Obligation
ProceedsFromIssuanceOfCollateralizedLoanObligation
847500000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
255000 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
135271000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
151167000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29711000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
26389000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5326000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5326000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
39592000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1172268000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
919000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9787000 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1036000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
87143000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
398461000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15698000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-98883000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250621000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273770000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266319000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174887000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
254096000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
173178000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12223000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1709000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266319000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
174887000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
95339000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
24715000 usd
CY2023Q1 kref Escrow Deposits Related To Financing Receivable
EscrowDepositsRelatedToFinancingReceivable
0 usd
CY2022Q1 kref Escrow Deposits Related To Financing Receivable
EscrowDepositsRelatedToFinancingReceivable
80870000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 kref Loan Modification Accounted For New Loan
LoanModificationAccountedForNewLoan
111000000 usd
CY2022Q1 kref Loan Modification Accounted For New Loan
LoanModificationAccountedForNewLoan
0 usd
CY2023Q1 us-gaap Dividends
Dividends
29711000 usd
CY2022Q1 us-gaap Dividends
Dividends
29211000 usd
CY2023Q1 kref Deferred Financing Costs Incurred But Not Yet Paid
DeferredFinancingCostsIncurredButNotYetPaid
2331000 usd
CY2022Q1 kref Deferred Financing Costs Incurred But Not Yet Paid
DeferredFinancingCostsIncurredButNotYetPaid
3314000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— The preparation of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">condensed consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes subjective estimates to project cash flows KREF expects to receive on its investments in loans and securities as well as the related market discount rates, which significantly impact the interest income, impairments, allowance for loan loss and fair values recorded or disclosed. Actual results could materially differ from those estimates.</span>
CY2023Q1 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
55600000 usd
CY2022Q4 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
54400000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
12200000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
10800000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
12200000 usd
CY2023Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
700000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
10800000 usd
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1100000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
4200000 usd
CY2023Q1 kref Real Estate Owned Liability
RealEstateOwnedLiability
3500000 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2200000 usd
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
4100000 usd
CY2022Q4 kref Real Estate Owned Liability
RealEstateOwnedLiability
3700000 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2100000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
60386000 usd
CY2023Q1 kref Incremental Common Shares Potentially Attributable To Dilutive Effect Of Conversion Of Debt Securities
IncrementalCommonSharesPotentiallyAttributableToDilutiveEffectOfConversionOfDebtSecurities
6316174 shares
CY2023Q1 kref Prepayment Fee Income
PrepaymentFeeIncome
400000 usd
CY2022Q1 kref Prepayment Fee Income
PrepaymentFeeIncome
0 usd
CY2023Q1 kref Net Accelerated Fees
NetAcceleratedFees
300000 usd
CY2022Q1 kref Net Accelerated Fees
NetAcceleratedFees
800000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
167360000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
106974000 usd
CY2023Q1 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
3.2
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
106974000 usd
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
4138000 usd
CY2022Q4 kref Allowance For Credit Loss
AllowanceForCreditLoss
111112000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
81000 usd
CY2023Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
60467000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
167360000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
4219000 usd
CY2023Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
171579000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
22244000 usd
CY2021Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1495000 usd
CY2021Q4 kref Allowance For Credit Loss
AllowanceForCreditLoss
23739000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1568000 usd
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
350000 usd
CY2022Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1218000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
20676000 usd
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1845000 usd
CY2022Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
22521000 usd
CY2023Q1 kref Allowance For Credit Loss
AllowanceForCreditLoss
171600000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
60500000 usd
CY2022Q1 kref Credit Loss Expense Reversal
CreditLossExpenseReversal
-1200000 usd
CY2021Q4 kref Real Estate Owned Other Assets Assumed
RealEstateOwnedOtherAssetsAssumed
2000000 usd
CY2023Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
81100000 usd
CY2022Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
80231000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1670000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2287000 usd
CY2023Q1 kref Other Real Estate Operations Income
OtherRealEstateOperationsIncome
576000 usd
CY2022Q1 kref Other Real Estate Operations Income
OtherRealEstateOperationsIncome
342000 usd
CY2023Q1 kref Property Operating Revenue
PropertyOperatingRevenue
2246000 usd
CY2022Q1 kref Property Operating Revenue
PropertyOperatingRevenue
2629000 usd
CY2023Q1 kref Property Operating Expense
PropertyOperatingExpense
2758000 usd
CY2022Q1 kref Property Operating Expense
PropertyOperatingExpense
2554000 usd
CY2023Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
288000 usd
CY2022Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
403000 usd
CY2023Q1 kref Income Loss From Real Estate Owned Operations
IncomeLossFromRealEstateOwnedOperations
-224000 usd
CY2022Q1 kref Income Loss From Real Estate Owned Operations
IncomeLossFromRealEstateOwnedOperations
478000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17000 usd
CY2023Q1 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
91000 usd
CY2022Q1 us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
91000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
50000 usd
CY2023Q1 us-gaap Below Market Lease Amortization Income Remainder Of Fiscal Year
BelowMarketLeaseAmortizationIncomeRemainderOfFiscalYear
274000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
67000 usd
CY2023Q1 us-gaap Below Market Lease Amortization Income Next Twelve Months
BelowMarketLeaseAmortizationIncomeNextTwelveMonths
365000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
67000 usd
CY2023Q1 us-gaap Below Market Lease Amortization Income Year Two
BelowMarketLeaseAmortizationIncomeYearTwo
365000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
67000 usd
CY2023Q1 us-gaap Below Market Lease Amortization Income Year Three
BelowMarketLeaseAmortizationIncomeYearThree
365000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
3362000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
1853000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
872000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
443000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
22000 usd
CY2023Q1 kref Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
0 usd
CY2023Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.311
CY2022Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.315
CY2023Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.301
CY2022Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.256
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
585818000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1479516000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1237952000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
542632000 usd
CY2023Q1 kref Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
48501000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3894419000 usd
CY2023Q1 kref Debt Instrument Covenant Interest Incometo Interest Expense Ratio
DebtInstrumentCovenantInterestIncometoInterestExpenseRatio
1.5
CY2023Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Minimum Percentageof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthMinimumPercentageofAggregateCashProceedsMadeandCapitalContributionsReceived
0.750
CY2023Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Amountof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthAmountofAggregateCashProceedsMadeandCapitalContributionsReceived
1353400000 usd
CY2023Q1 kref Debt Instrument Covenant Cash Liquidity Amount
DebtInstrumentCovenantCashLiquidityAmount
10000000 usd
CY2023Q1 kref Debt Instrument Covenant Cash Liquidity Percentof Recourse Indebtedness
DebtInstrumentCovenantCashLiquidityPercentofRecourseIndebtedness
0.050
CY2023Q1 kref Debt Instrument Covenant Total Indebtedness Percentof Total Assets
DebtInstrumentCovenantTotalIndebtednessPercentofTotalAssets
0.833
CY2023Q1 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.289
CY2022Q4 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.284
CY2023Q1 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2022Q4 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2014Q4 kref Common Stockand Preferred Stock Shares Authorized
CommonStockandPreferredStockSharesAuthorized
350000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75080707 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75080707 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69095011 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69095011 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5985696 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5985696 shares
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
100000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29711000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29211000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
29211000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5326000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5326000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29796000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2023Q1 kref Incremental Common Shares Potentially Attributable To Dilutive Effect Of Conversion Of Debt Securities
IncrementalCommonSharesPotentiallyAttributableToDilutiveEffectOfConversionOfDebtSecurities
6316174 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-25077000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
35468000 usd
CY2023Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
5326000 usd
CY2022Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
5326000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
407000 usd
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
346000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30810000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30810000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
29796000 usd
CY2023Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2022Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
2201000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 usd
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
25000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-30810000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
31972000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69095011 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63086452 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
6316174 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69095011 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69402626 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20426 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
181560 shares
CY2023Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
8458000 usd
CY2022Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
8722000 usd
CY2023Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
9487000 usd
CY2022Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6733000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
167400000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
107000000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
7464320000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
200000 usd
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd

Files In Submission

Name View Source Status
0001631596-23-000023-index-headers.html Edgar Link pending
0001631596-23-000023-index.html Edgar Link pending
0001631596-23-000023.txt Edgar Link pending
0001631596-23-000023-xbrl.zip Edgar Link pending
a202303-exhibit101.htm Edgar Link pending
a202303-exhibit311.htm Edgar Link pending
a202303-exhibit312.htm Edgar Link pending
a202303-exhibit321.htm Edgar Link pending
a202303-exhibit322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kref-20230331.htm Edgar Link pending
kref-20230331.xsd Edgar Link pending
kref-20230331_g1.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kref-20230331_cal.xml Edgar Link unprocessable
kref-20230331_def.xml Edgar Link unprocessable
kref-20230331_g2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
kref-20230331_htm.xml Edgar Link completed
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
kref-20230331_lab.xml Edgar Link unprocessable
kref-20230331_pre.xml Edgar Link unprocessable